Bo-yi Qin

Title: Innovations in Opioid Analgesics: The Contributions of Bo-yi Qin

Introduction

Bo-yi Qin is an esteemed inventor based in Beijing, China, known for his groundbreaking work in the field of opioid analgesics. With a portfolio that includes two patents, Qin has made significant contributions to the development of methods aimed at creating low- or non-addictive pain relief options.

Latest Patents

Qin’s latest inventions include a method for the identification of low/non-addictive opioid analgesics. This innovative approach utilizes a bioassay, consisting of an electrophysiological method and a cell culture system of dorsal-root ganglion (DRG) neurons, to effectively screen and identify opioids that have a high potential for use as safe pain relief alternatives. One remarkable aspect of this invention is the identification of a specific group of opioid alkaloids and their analogues, which can uniquely activate only inhibitory opioid receptor functions while avoiding excitatory responses. Furthermore, the invention explores the specific applications of etorphine and dihydroetorphine from the opioid alkaloid family, emphasizing their potential as low- or non-addictive analgesics and their role in the treatment of opioid addiction.

Career Highlights

Currently working at United Biomedical, Inc., Bo-yi Qin has established himself as a key figure in opioid research and innovation. His expertise lies in developing advanced analgesic methods that prioritize patient safety and addiction prevention, which is pivotal in today's healthcare landscape.

Collaborations

Qin works alongside prominent colleagues such as Xiong-qi Gong and Mao Huang, pooling their expertise to drive forward the research and development of groundbreaking analgesic methods. Their collaborative efforts significantly enhance the potential for innovative solutions that combat pain while addressing the critical issue of opioid addiction.

Conclusion

Bo-yi Qin's contributions to the field of opioid analgesics mark a significant step toward safer pain management solutions. His latest patents reflect a commitment to addressing pressing medical challenges, paving the way for future innovations in the treatment of pain and addiction.